JP Morgan Initiates Coverage On Tango Therapeutics with Overweight Rating, Announces Price Target of $46
Benzinga Newsdesk 3 months ago
NewsInitiationAnalyst RatingsPrice Target
JP Morgan analyst Brian Cheng initiates coverage on Tango Therapeutics (NASDAQ:TNGX) with a Overweight rating and announces Price Target of $46.
JP Morgan analyst Brian Cheng initiates coverage on Tango Therapeutics (NASDAQ:TNGX) with a Overweight rating and announces Price Target of $46.